<DOC>
	<DOCNO>NCT02574195</DOCNO>
	<brief_summary>The main aim present study evaluate prevalence individual microvascular macrovascular complication among diabetes mellitus patient determine percentage diabetes mellitus patient achieve HbA1c &lt; 7,0 % .</brief_summary>
	<brief_title>Evolution Effectiveness Diabetes Medical Care Russia</brief_title>
	<detailed_description>Rationale Study Primary Existing routine health statistic underestimates rate morbidity due diabetes complication . To provide realistic estimation morbidity , repeat epidemiological study essential assessment tendency diabetes medical care country level . They allow reveal issue , , resolve , contribute improvement diabetes medical care effectiveness . Guidelines develop study data may save healthcare budget prevent financial loss due diabetes-related morbidity disability . Objectives Study • Primary objective : To determine prevalence individual microvascular macrovascular complication among patient diabetes mellitus type 1 type 2 • Secondary objective : To determine percentage patient diabetes mellitus type 1 type 2 achieve HbA1c &lt; 7,0 % . Study design The hired medical team ( 9 specialist ) go perform technical study-related task Moscow Region . Target population include approximately 147,000 diabetes mellitus patient include Regional Diabetes Mellitus Register , patient select via random sampling ( 600 patient ) . A special rented medical bus accommodate study personnel place local study-related activity . After obtain write Informed Consent Form local endocrinologist study subject one study visit , appear fast follow data collect , test examination perform : - date diagnosis type 1 type 2 diabetes mellitus ; - medical history include coronary heart disease , myocardial infarction , coronary revascularization , cerebrovascular disease ( ischaemic stroke , transient ischemic attack ) , peripheral artery disease , diabetic retinopathy ( type , stage , year diagnosis ) , diabetic neuropathy , chronic kidney disease , diabetic foot ; - blood test HbA1c , serum total cholesterol , triglyceride , HDL- cholesterol , serum creatinine estimation estimate Glomerular filtration rate standard CKD-EPI , alanine-aminotransferase , aspartate-aminotransferase ; - urine analysis albumin spot urine ; - measurement height , weight/BMI ; - measurement sit blood pressure , Electocardiogramm ; - eye examination , include fundoscopy ; - foot examination , include test touch , pain , temperature , vibration sensation toe mini-doppler ultrasound vessel study ; - current pharmacological therapy regimen ( medication , daily dos ) . The medical team admit 35 study subject per day . This study descriptive character . There comparison perform .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Inclusion criterion : The subject population study must meet following criterion : 1 . Provision sing subject informed consent 2 . Type 1 type 2 diabetes mellitus Target population include approximately 147,000 diabetes mellitus patient include Regional DM Register , patient select via random sampling ( 600 patient ) . The prescription medicinal product clearly separated decision include subject study . Exclusion criterion : 1 . Diagnosis gestational diabetes mellitus alone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>microvascular complication</keyword>
	<keyword>macrovascular complication</keyword>
	<keyword>epidemiology</keyword>
	<keyword>Russia</keyword>
</DOC>